vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and VALVOLINE INC (VVV). Click either name above to swap in a different company.

VALVOLINE INC is the larger business by last-quarter revenue ($461.8M vs $236.8M, roughly 2.0× CROSS COUNTRY HEALTHCARE INC). VALVOLINE INC runs the higher net margin — -7.1% vs -35.0%, a 27.9% gap on every dollar of revenue. On growth, VALVOLINE INC posted the faster year-over-year revenue change (11.5% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $7.4M). Over the past eight quarters, VALVOLINE INC's revenue compounded faster (9.0% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Valvoline Inc. is an American retail automotive services company based in Lexington, Kentucky. It licenses the name for a number of Valvoline-labeled automotive oil, additives, and lubricants. It also owns the Valvoline Instant Oil Change, Great Canadian Oil Change and Valvoline Express Care car repair chains. As of 2023, it is the second largest oil change service provider in the United States with 10% market share and over 1,650 locations.

CCRN vs VVV — Head-to-Head

Bigger by revenue
VVV
VVV
2.0× larger
VVV
$461.8M
$236.8M
CCRN
Growing faster (revenue YoY)
VVV
VVV
+35.1% gap
VVV
11.5%
-23.6%
CCRN
Higher net margin
VVV
VVV
27.9% more per $
VVV
-7.1%
-35.0%
CCRN
More free cash flow
CCRN
CCRN
$8.7M more FCF
CCRN
$16.1M
$7.4M
VVV
Faster 2-yr revenue CAGR
VVV
VVV
Annualised
VVV
9.0%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCRN
CCRN
VVV
VVV
Revenue
$236.8M
$461.8M
Net Profit
$-82.9M
$-32.8M
Gross Margin
37.4%
Operating Margin
-30.2%
4.0%
Net Margin
-35.0%
-7.1%
Revenue YoY
-23.6%
11.5%
Net Profit YoY
-2109.7%
-135.8%
EPS (diluted)
$-2.56
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
VVV
VVV
Q4 25
$236.8M
$461.8M
Q3 25
$250.1M
$453.8M
Q2 25
$274.1M
$439.0M
Q1 25
$293.4M
$403.2M
Q4 24
$309.9M
$414.3M
Q3 24
$315.1M
$435.5M
Q2 24
$339.8M
$421.4M
Q1 24
$379.2M
$388.7M
Net Profit
CCRN
CCRN
VVV
VVV
Q4 25
$-82.9M
$-32.8M
Q3 25
$-4.8M
$25.0M
Q2 25
$-6.7M
$56.5M
Q1 25
$-490.0K
$37.6M
Q4 24
$-3.8M
$91.6M
Q3 24
$2.6M
$92.3M
Q2 24
$-16.1M
$45.9M
Q1 24
$2.7M
$41.4M
Gross Margin
CCRN
CCRN
VVV
VVV
Q4 25
37.4%
Q3 25
20.4%
39.1%
Q2 25
20.4%
40.5%
Q1 25
20.0%
37.3%
Q4 24
36.9%
Q3 24
20.4%
39.1%
Q2 24
20.8%
39.7%
Q1 24
20.4%
37.6%
Operating Margin
CCRN
CCRN
VVV
VVV
Q4 25
-30.2%
4.0%
Q3 25
-2.4%
18.6%
Q2 25
-2.1%
21.6%
Q1 25
-0.3%
16.6%
Q4 24
-1.1%
34.7%
Q3 24
0.9%
30.9%
Q2 24
-5.7%
22.2%
Q1 24
0.8%
19.7%
Net Margin
CCRN
CCRN
VVV
VVV
Q4 25
-35.0%
-7.1%
Q3 25
-1.9%
5.5%
Q2 25
-2.4%
12.9%
Q1 25
-0.2%
9.3%
Q4 24
-1.2%
22.1%
Q3 24
0.8%
21.2%
Q2 24
-4.7%
10.9%
Q1 24
0.7%
10.7%
EPS (diluted)
CCRN
CCRN
VVV
VVV
Q4 25
$-2.56
$-0.26
Q3 25
$-0.15
$0.20
Q2 25
$-0.20
$0.44
Q1 25
$-0.02
$0.29
Q4 24
$-0.13
$0.71
Q3 24
$0.08
$0.70
Q2 24
$-0.47
$0.35
Q1 24
$0.08
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
VVV
VVV
Cash + ST InvestmentsLiquidity on hand
$108.7M
$69.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$307.6M
Total Assets
$449.0M
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
VVV
VVV
Q4 25
$108.7M
$69.9M
Q3 25
$99.1M
$51.6M
Q2 25
$81.2M
$68.3M
Q1 25
$80.7M
$61.9M
Q4 24
$81.6M
$60.0M
Q3 24
$64.0M
$68.3M
Q2 24
$69.6M
$65.7M
Q1 24
$5.2M
$494.5M
Stockholders' Equity
CCRN
CCRN
VVV
VVV
Q4 25
$322.8M
$307.6M
Q3 25
$408.1M
$338.5M
Q2 25
$412.2M
$313.6M
Q1 25
$418.2M
$248.7M
Q4 24
$419.0M
$229.8M
Q3 24
$424.7M
$185.6M
Q2 24
$433.3M
$106.5M
Q1 24
$462.4M
$60.1M
Total Assets
CCRN
CCRN
VVV
VVV
Q4 25
$449.0M
$3.4B
Q3 25
$538.2M
$2.7B
Q2 25
$553.8M
$2.6B
Q1 25
$576.2M
$2.5B
Q4 24
$589.3M
$2.3B
Q3 24
$597.4M
$2.4B
Q2 24
$602.9M
$2.4B
Q1 24
$648.4M
$2.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
VVV
VVV
Operating Cash FlowLast quarter
$18.2M
$64.8M
Free Cash FlowOCF − Capex
$16.1M
$7.4M
FCF MarginFCF / Revenue
6.8%
1.6%
Capex IntensityCapex / Revenue
0.9%
12.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$57.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
VVV
VVV
Q4 25
$18.2M
$64.8M
Q3 25
$20.1M
$121.9M
Q2 25
$4.2M
$86.9M
Q1 25
$5.7M
$47.2M
Q4 24
$24.2M
$41.2M
Q3 24
$7.5M
$101.3M
Q2 24
$82.4M
$75.6M
Q1 24
$6.0M
$68.3M
Free Cash Flow
CCRN
CCRN
VVV
VVV
Q4 25
$16.1M
$7.4M
Q3 25
$17.9M
$23.0M
Q2 25
$2.3M
$32.0M
Q1 25
$3.8M
$-4.6M
Q4 24
$21.7M
$-12.4M
Q3 24
$6.3M
$29.9M
Q2 24
$79.6M
$9.8M
Q1 24
$3.8M
$23.4M
FCF Margin
CCRN
CCRN
VVV
VVV
Q4 25
6.8%
1.6%
Q3 25
7.2%
5.1%
Q2 25
0.8%
7.3%
Q1 25
1.3%
-1.1%
Q4 24
7.0%
-3.0%
Q3 24
2.0%
6.9%
Q2 24
23.4%
2.3%
Q1 24
1.0%
6.0%
Capex Intensity
CCRN
CCRN
VVV
VVV
Q4 25
0.9%
12.4%
Q3 25
0.9%
21.8%
Q2 25
0.7%
12.5%
Q1 25
0.6%
12.8%
Q4 24
0.8%
12.9%
Q3 24
0.4%
16.4%
Q2 24
0.8%
15.6%
Q1 24
0.6%
11.6%
Cash Conversion
CCRN
CCRN
VVV
VVV
Q4 25
Q3 25
4.88×
Q2 25
1.54×
Q1 25
1.26×
Q4 24
0.45×
Q3 24
2.92×
1.10×
Q2 24
1.65×
Q1 24
2.23×
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

VVV
VVV

Oil Change And Related Fees$337.7M73%
Non Oil Change And Related Fees$100.5M22%
Franchise Fees And Other$23.6M5%

Related Comparisons